Hirak Der-Torossian

6PUBLICATIONS
79CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 08, 2024
Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer.

Rona Yaeger, Nataliya V Uboha, Meredith S Pelster

|Jun 16, 2023
Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRAS-Mutated Non-Small-Cell Lung Cancer Who Have Untreated CNS Metastases.

Marcelo V Negrao, Alexander I Spira, Rebecca S Heist

|Apr 26, 2023
Adagrasib in Advanced Solid Tumors Harboring a KRAS Mutation.

Tanios S Bekaii-Saab, Rona Yaeger, Alexander I Spira

|Nov 10, 2022
Molecular Characterization of Acquired Resistance to KRASG12C-EGFR Inhibition in Colorectal Cancer.

Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli

|Apr 20, 2022
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy.

Pavlos Msaouel, Sangeeta Goswami, Peter F Thall

Pageof 1